Articles dans des revues avec comité de lecture (224)
  1. 127. Malki, K., Uher, R., Paya-Cano, J., Binder, E., Rietschel, M., Zobel, A., Mors, O., Hauser, J. W., Henigsberg, N., Jerman, B., Souery, D., Placentino, A., Ng, M. M., Cohen-Woods, S., Sluyter, F., Farmer, A., Aitchison, K., Craig, I., Lewis, C. C., McGuffin, P., & Schalkwyk, L. L. (2011). Convergent animal and human evidence suggests a role of PPM1A gene in response to antidepressants. Biological psychiatry, 69(4), 360-365. doi:10.1016/j.biopsych.2010.08.011
  2. 128. Aygun Kocabas, N., Antonijevic, I., Faghel, C., Forray, C., Kasper, S., Lecrubier, Y., Linotte, S., Massat, I., Mendlewicz, J., Noro, M., Montgomery, S., Oswald, P., Snyder, L., Zohar, J., & Souery, D. (2011). Brain-derived neurotrophic factor gene polymorphisms: influence on treatment response phenotypes of major depressive disorder. International clinical psychopharmacology, 26(1), 1-10. doi:10.1097/YIC.0b013e32833d18f8
  3. 129. Serretti, A., Chiesa, A., Calati, R., Massat, I., Linotte, S., Kasper, S., Lecrubier, Y., Antonijevic, I., Forray, C., Snyder, L., Bollen, J., Zohar, J., De Ronchi, D., Souery, D., & Mendlewicz, J. (2011). A preliminary investigation of the influence of CREB1 gene on treatment resistance in major depression. Journal of affective disorders, 128(1-2), 56-63. doi:10.1016/j.jad.2010.06.025
  4. 130. Aygun Kocabas, N., Antonijevic, I., Faghel, C., Forray, C., Kasper, S., Lecrubier, Y., Linotte, S., Massat, I., Montgomery, S., Noro, M., Oswald, P., Snyder, L., Souery, D., Zohar, J., & Mendlewicz, J. (2010). Dysbindin gene (DTNBP1) in major depressive disorder (MDD) patients: lack of association with clinical phenotypes. The world journal of biological psychiatry, 11(8), 985-990. doi:10.3109/15622975.2010.512089
  5. 131. Mendlewicz, J., Massat, I., Linotte, S., Kasper, S., Konstantinidis, A., Lecrubier, Y., Montgomery, S., Serretti, A., Zohar, J., Souery, D., & Group for the Study of Resistant Depression (GSRD), (2010). Identification of clinical factors associated with resistance to antidepressants in bipolar depression: results from an European Multicentre Study. International clinical psychopharmacology, 25(5), 297-301. doi:10.1097/YIC.0b013e32833c4ceb
  6. 132. Uher, R., Aitchison, K., Farmer, A., McGuffin, P., Muthén, B., Souery, D., Mors, O., Jaracz, J., Placentino, A., Petrovic, A., Zobel, A., Henigsberg, N., & Rietschel, M. (2010). Trajectories of change in depression severity during treatment with antidepressants. Psychological medicine, 40(8), 1367-1377. doi:10.1017/S0033291709991528
  7. 133. Aygun Kocabas, N., Faghel, C., Barreto, M. I., Kasper, S., Linotte, S., Mendlewicz, J., Noro, M., Oswald, P., Souery, D., Zohar, J., & Massat, I. (2010). The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study. International clinical psychopharmacology, 25(4), 218-227. doi:10.1097/YIC.0b013e328338b884
  8. 134. Noro, M., Antonijevic, I., Forray, C., Kasper, S., Aygun Kocabas, N., Lecrubier, Y., Linotte, S., Mendlewicz, J., Montgomery, S., Snyder, L., Souery, D., Verbanck, P., Zohar, J., & Massat, I. (2010). 5HT1A and 5HT2A receptor genes in treatment response phenotypes in major depressive disorder. International clinical psychopharmacology, 25(4), 228-231. doi:10.1097/YIC.0b013e328338bcf4
  9. 135. Perroud, N., Uher, R., McGuffin, P., Aitchison, K., Farmer, A., Hauser, J. W., Dmitrzak-Weglarz, M., Rietschel, M., Strohmaier, J., Henigsberg, N., Kovacic, Z., Placentino, A., Giovannini, C., Kozel, D., Maier, W., Zobel, A., Mors, O., Jorgensen, L., Souery, D., & Mendlewicz, J. (2010). History of suicide attempts among patients with depression in the GENDEP project. Journal of affective disorders, 123(1-3), 131-137. doi:10.1016/j.jad.2009.09.001
  10. 136. Uher, R., Mors, O., Hauser, J. W., Rietschel, M., Maier, W., Kozel, D., Henigsberg, N., Souery, D., Placentino, A., Perroud, N., Dernovsek, M. Z., Strohmaier, J., Larsen, E. R., Zobel, A., Leszczynska-Rodziewicz, A., Kalember, P., Pedrini, L., Linotte, S., Gunasinghe, C., Aitchison, K., McGuffin, P., & Farmer, A. (2009). Body weight as a predictor of antidepressant efficacy in the GENDEP project. Journal of affective disorders, 118(1-3), 147-154. doi:10.1016/j.jad.2009.02.013
  11. 137. Perroud, N., Aitchison, K., Uher, R., Smith, R. P., Huezo-Diaz, P., Marusic, A., Maier, W., Mors, O., Placentino, A., Henigsberg, N., Rietschel, M., Hauser, J. W., Souery, D., Kapelski, P., Bonvicini, C., Zobel, A., Jorgensen, L., Petrovic, A., Kalember, P., Schulze, T., Gupta, B., Gray, J., Lewis, C., Farmer, A., McGuffin, P., & Craig, I. (2009). Genetic predictors of increase in suicidal ideation during antidepressant treatment in the GENDEP project. Neuropsychopharmacology, 34(12), 2517-2528. doi:10.1038/npp.2009.81
  12. 138. Perroud, N., Uher, R., Marusic, A., Rietschel, M., Mors, O., Henigsberg, N., Hauser, J. W., Maier, W., Souery, D., Placentino, A., Szczepankiewicz, A., Jorgensen, L., Strohmaier, J., Zobel, A., Giovannini, C., Elkin, A., Gunasinghe, C., Gray, J., Campbell, D., Gupta, B., Farmer, A., McGuffin, P., & Aitchison, K. (2009). Suicidal ideation during treatment of depression with escitalopram and nortriptyline in Genome-Based Therapeutic Drugs for Depression (GENDEP): A clinical trial. BMC medicine, 7, 1741, 60. doi:10.1186/1741-7015-7-60
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 Suivant >>